GABA-A Receptor Neurons

GABA-A Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABA-A Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Ionotropic GABA receptors</td>
</tr>
<tr>
<td class="label">Primary Receptor</td>
<td>GABA-A (ionotropic, Cl- channel)</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>GABRA, GABRB, GABRG, GABRD, etc.

GABA-A Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GABA-A Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Ionotropic GABA receptors</td>
</tr>
<tr>
<td class="label">Primary Receptor</td>
<td>GABA-A (ionotropic, Cl- channel)</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>GABRA, GABRB, GABRG, GABRD, etc. (19 subunits)</td>
</tr>
<tr>
<td class="label">Signal Transduction</td>
<td>Ionotropic (Cl- influx, hyperpolarization)</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Throughout CNS; highest in cortex, hippocampus, cerebellum</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Postsynaptic (majority), extrasynaptic</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Subunit Class</td>
<td>Members</td>
</tr>
<tr>
<td class="label">α (alpha)</td>
<td>α1-α6</td>
</tr>
<tr>
<td class="label">β (beta)</td>
<td>β1-β3</td>
</tr>
<tr>
<td class="label">γ (gamma)</td>
<td>γ1-γ3</td>
</tr>
<tr>
<td class="label">δ (delta)</td>
<td>δ</td>
</tr>
<tr>
<td class="label">ρ (rho)</td>
<td>ρ1-ρ3</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Architecture</td>
</tr>
<tr>
<td class="label">α1β2γ2</td>
<td>α1β2γ2</td>
</tr>
<tr>
<td class="label">α2β2γ2</td>
<td>α2β2γ2</td>
</tr>
<tr>
<td class="label">α3β2γ2</td>
<td>α3β2γ2</td>
</tr>
<tr>
<td class="label">α5β2γ2</td>
<td>α5β2γ2</td>
</tr>
<tr>
<td class="label">α4βδ</td>
<td>α4βδ</td>
</tr>
<tr>
<td class="label">Subunits</td>
<td>α1, α2, β2/3, γ2</td>
</tr>
<tr>
<td class="label">GABA source</td>
<td>Vesicular release</td>
</tr>
<tr>
<td class="label">Current duration</td>
<td>Brief (~50 ms)</td>
</tr>
<tr>
<td class="label">Deactivation</td>
<td>Fast</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Synaptic junction</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>↑ Cl- conductance</td>
</tr>
<tr>
<td class="label">Barbiturates</td>
<td>Prolong channel open time</td>
</tr>
<tr>
<td class="label">GAT-1 inhibitors</td>
<td>Block reuptake</td>
</tr>
<tr>
<td class="label">GABA-T inhibitors</td>
<td>Block degradation</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Diazepam</td>
<td>α1,2,3,5</td>
</tr>
<tr>
<td class="label">Lorazepam</td>
<td>α1,2,3,5</td>
</tr>
<tr>
<td class="label">Alprazolam</td>
<td>α1,2,3,5</td>
</tr>
<tr>
<td class="label">Phenobarbital</td>
<td>α1,2,3,5</td>
</tr>
<tr>
<td class="label">Zolpidem</td>
<td>α1</td>
</tr>
<tr>
<td class="label">Tiagabine</td>
<td>GAT-1</td>
</tr>
<tr>
<td class="label">Vigabatrin</td>
<td>GABA-T</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">LSA-1</td>
<td>α5 positive</td>
</tr>
<tr>
<td class="label">Basmisanil</td>
<td>α5 negative</td>
</tr>
<tr>
<td class="label">TPA-023</td>
<td>α2,α3 positive</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Patch-clamp electrophysiology</td>
<td>Single-channel and whole-cell recording</td>
</tr>
<tr>
<td class="label">Radioligand binding</td>
<td>Receptor density and affinity</td>
</tr>
<tr>
<td class="label">Immunohistochemistry</td>
<td>Subunit localization</td>
</tr>
<tr>
<td class="label">Knockout mice</td>
<td>Subtype-specific function</td>
</tr>
<tr>
<td class="label">Point mutagenesis</td>
<td>Ligand binding sites</td>
</tr>
<tr>
<td class="label">Cryo-EM</td>
<td>Structural biology</td>
</tr>
</table>

Gaba A Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

GABA-A receptor neurons constitute the primary mechanism for fast inhibitory neurotransmission in the mammalian brain. These ligand-gated chloride channels are expressed throughout the central nervous system and play fundamental roles in maintaining neural circuit balance, regulating neuronal excitability, and modulating cognitive functions. Dysfunction of GABA-A receptor signaling is implicated in numerous neurological and psychiatric disorders, including epilepsy, anxiety, Alzheimer's disease, and Parkinson's disease. [@sigel2012]

Overview

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Biology

Receptor Subunit Composition

GABA-A receptors are pentameric assemblies of 19 possible subunits:

Common Receptor Subtypes

Structural Features

• Pentameric assembly: Five subunits arranged around central Cl- pore
• GABA binding site: Interface between α and β subunits
• Benzodiazepine site: Interface between α and γ subunits
• Transmembrane domains: Four (M1-M4) per subunit
• Intracellular loop: Phosphorylation sites for modulation

Neurophysiology

Fast Inhibitory Synaptic Transmission

Tonic Inhibition

Extrasynaptic GABA-A receptors (α4, α5, δ subunits):

• High affinity for GABA
• Sustained Cl- current during ambient GABA
• Shunting inhibition without hyperpolarization
• Network oscillation regulation

Synaptic vs. Extrasynaptic

Clinical Significance

Epilepsy

GABA-A receptors are primary therapeutic targets:

• Benzodiazepines: Allosteric positive modulators (diazepam, lorazepam)
• Barbiturates: Direct channel activators (phenobarbital)
• Tiagabine: GAT-1 inhibitor (increases synaptic GABA)
• Vigabatrin: GABA-T inhibitor (increases GABA levels)

Anxiety Disorders

• α2-containing receptors: Anxiolytic effects
• α3-containing receptors: Anxiolytic, muscle relaxation
• α1-containing receptors: Sedation (undesired for anxiolysis)
• Benzodiazepine dependence: Tolerance and withdrawal

Alzheimer's Disease

GABAergic dysfunction contributes to AD pathophysiology:

• Reduced GABA levels in AD hippocampus
• Altered GABA-A subunit expression (↓α1, ↓α5)
• Excitotoxicity from reduced inhibition
• Cognitive deficits from network dysfunction

Parkinson's Disease

• GABA-A modulation affects motor cortex excitability
• Deep brain stimulation alters GABAergic signaling
• L-DOPA-induced dyskinesias involve GABAergic system
• GABA-A agonists may improve motor symptoms

Sleep Disorders

• α1-containing receptors: Sedative/hypnotic effects
• Zolpidem: Selective α1 modulator (Imimba)
• α3-containing receptors: Sleep architecture
• Extrasynaptic receptors: Tonic inhibition in sleep circuits

Neurodegeneration Mechanisms

Excitotoxicity

• GABA dysfunction leads to excessive excitation
• Glutamate toxicity unchecked by inadequate inhibition
• Calcium dysregulation from depolarization
• Cell death pathways activation

Neuroinflammation

• GABAergic signaling modulates microglial activation
• Anti-inflammatory effects of GABA-A activation
• Cytokine regulation through GABA pathways
• Therapeutic potential for neuroinflammation

Oxidative Stress

• GABA has antioxidant properties
• Mitochondrial function regulated by GABA signaling
• Protection against ROS
• Therapeutic implications for neurodegeneration

Synaptic Plasticity

• LTPmechanisms/long-term-potentiation)/LTD modulation by GABA-A receptors
• Memory formation requires balanced inhibition
• α5-containing receptors in hippocampal plasticity
• Cognitive enhancement via α5 negative modulators

Therapeutic Agents

FDA-Approved Drugs

Investigational Compounds

Research Methods

Experimental Techniques

Transgenic Models

• α1 subunit KO: Sedation-resistant
• α2 subunit KO: Anxiolytic-resistant
• α5 subunit KO: Enhanced memory
• γ2 subunit KO: Lethal (developmental)

Side Effects and Limitations

Benzodiazepine Concerns

• Tolerance: Receptor desensitization
• Dependence: Withdrawal symptoms
• Sedation: α1-mediated
• Cognitive impairment: Memory disruption
• Respiratory depression: High doses

Alternatives to Benzodiazepines

• 5-HT1A agonists: Buspirone (anxiety)
• SSRIs: Sertraline (anxiety, depression)
• Pregabalin: α2δ subunit modulation
• Mebicar: GABA-A modulation (Russia)

See Also

• [GABA-B Receptor Neurons](/cell-types/gaba-b-receptor-neurons)
• [GABA Neurotransmission](/mechanisms/gaba-signaling)
• [GABAergic Neurons](/cell-types/gabaergic-neurons)
• [Glutamate-GABA Balance](/mechanisms/glutamate-gaba-balance)
• [Hippocampal CA1 Neurons](/cell-types/hippocampal-ca1-neurons)
• [Cortical Pyramidal Neurons](/cell-types/cortical-pyramidal-neurons)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Anxiety Disorders](/diseases/anxiety-disorders)
• [GABA-A Receptor Protein](/proteins/gaba-a-receptor)
• [GABRA1 Gene](/genes/gabra1)
• [GABRB3 Gene](/genes/gabrb3)

Background

The study of Gaba A Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data